EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
32 hedge funds and large institutions have $213M invested in ESSA Pharma in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.26% less ownership
Funds ownership: 79.37% → 79.11% (-0.26%)
46% less call options, than puts
Call options by funds: $120K | Put options by funds: $224K
Holders
32
Holding in Top 10
–
Calls
$120K
Puts
$224K
Top Buyers
| 1 | +$5.83M | |
| 2 | +$569K | |
| 3 | +$470K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$168K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$40.2K |
Top Sellers
| 1 | -$5.19M | |
| 2 | -$1.35M | |
| 3 | -$229K | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$60.6K |
| 5 |
Two Sigma Investments
New York
|
-$54.2K |